A detailed history of Stephens Investment Management Group LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Stephens Investment Management Group LLC holds 674,566 shares of TECH stock, worth $48.2 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares
674,566
Previous 680,264 0.84%
Holding current value
$48.2 Million
Previous $48.7 Million 10.59%
% of portfolio
0.76%
Previous 0.7%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$70.96 - $82.35 $404,330 - $469,230
-5,698 Reduced 0.84%
674,566 $53.9 Million
Q2 2024

Aug 06, 2024

SELL
$62.12 - $84.15 $604,924 - $819,452
-9,738 Reduced 1.41%
680,264 $48.7 Million
Q1 2024

May 14, 2024

BUY
$65.98 - $77.09 $104,578 - $122,187
1,585 Added 0.23%
690,002 $48.6 Million
Q4 2023

Feb 13, 2024

SELL
$52.83 - $78.22 $573,680 - $849,390
-10,859 Reduced 1.55%
688,417 $53.1 Million
Q3 2023

Nov 14, 2023

BUY
$67.52 - $89.42 $1.87 Million - $2.47 Million
27,660 Added 4.12%
699,276 $47.6 Million
Q2 2023

Aug 14, 2023

BUY
$73.76 - $85.98 $1.13 Million - $1.32 Million
15,319 Added 2.33%
671,616 $54.8 Million
Q1 2023

May 15, 2023

BUY
$71.62 - $86.62 $350,365 - $423,745
4,892 Added 0.75%
656,297 $48.7 Million
Q4 2022

Jan 26, 2023

BUY
$80.67 - $352.29 $39.3 Million - $172 Million
487,014 Added 296.25%
651,405 $55 Million
Q3 2022

Nov 07, 2022

BUY
$282.54 - $391.85 $316,727 - $439,263
1,121 Added 0.69%
164,391 $46.7 Million
Q2 2022

Aug 03, 2022

SELL
$322.67 - $449.65 $112,611 - $156,927
-349 Reduced 0.21%
163,270 $56.6 Million
Q1 2022

May 04, 2022

BUY
$353.85 - $487.79 $682,930 - $941,434
1,930 Added 1.19%
163,619 $70.9 Million
Q4 2021

Feb 15, 2022

SELL
$456.15 - $525.06 $213,022 - $245,203
-467 Reduced 0.29%
161,689 $83.6 Million
Q3 2021

Oct 27, 2021

SELL
$444.87 - $538.88 $1.21 Million - $1.46 Million
-2,716 Reduced 1.65%
162,156 $78.6 Million
Q2 2021

Aug 09, 2021

SELL
$387.35 - $450.26 $6.54 Million - $7.6 Million
-16,890 Reduced 9.29%
164,872 $74.2 Million
Q1 2021

May 14, 2021

BUY
$314.62 - $411.0 $4.72 Million - $6.17 Million
15,011 Added 9.0%
181,762 $69.4 Million
Q4 2020

Feb 10, 2021

SELL
$246.9 - $321.87 $1.25 Million - $1.63 Million
-5,069 Reduced 2.95%
166,751 $53 Million
Q3 2020

Nov 13, 2020

BUY
$232.22 - $282.96 $18.7 Million - $22.8 Million
80,574 Added 88.3%
171,820 $42.6 Million
Q2 2020

Aug 24, 2020

SELL
$185.43 - $279.56 $277,959 - $419,060
-1,499 Reduced 1.62%
91,246 $24.1 Million
Q1 2020

May 14, 2020

BUY
$161.17 - $221.51 $1.31 Million - $1.8 Million
8,125 Added 9.6%
92,745 $17.6 Million
Q4 2019

Feb 14, 2020

SELL
$189.68 - $222.09 $375,566 - $439,738
-1,980 Reduced 2.29%
84,620 $18.6 Million
Q3 2019

Oct 18, 2019

SELL
$183.56 - $216.72 $916,698 - $1.08 Million
-4,994 Reduced 5.45%
86,600 $16.9 Million
Q2 2019

Aug 01, 2019

SELL
$188.72 - $215.43 $638,062 - $728,368
-3,381 Reduced 3.56%
91,594 $19.1 Million
Q1 2019

May 03, 2019

SELL
$136.09 - $200.44 $151,604 - $223,290
-1,114 Reduced 1.16%
94,975 $18.9 Million
Q4 2018

Feb 11, 2019

SELL
$132.75 - $203.8 $675,033 - $1.04 Million
-5,085 Reduced 5.03%
96,089 $13.9 Million
Q3 2018

Nov 14, 2018

SELL
$147.44 - $204.11 $1.11 Million - $1.54 Million
-7,545 Reduced 6.94%
101,174 $20.7 Million
Q2 2018

Aug 10, 2018

SELL
$144.9 - $165.58 $872,442 - $996,957
-6,021 Reduced 5.25%
108,719 $16 Million
Q1 2018

May 04, 2018

BUY
$131.46 - $151.04 $1.92 Million - $2.21 Million
14,617 Added 14.6%
114,740 $17.3 Million
Q4 2017

Feb 05, 2018

SELL
$121.17 - $134.75 $294,079 - $327,038
-2,427 Reduced 2.37%
100,123 $13 Million
Q3 2017

Nov 08, 2017

BUY
$113.59 - $123.78 $382,003 - $416,272
3,363 Added 3.39%
102,550 $12.4 Million
Q2 2017

Aug 10, 2017

BUY
N/A
99,187
99,187 $11.7 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.8B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Stephens Investment Management Group LLC Portfolio

Follow Stephens Investment Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Investment Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stephens Investment Management Group LLC with notifications on news.